Venetoclax shows potential for R/R hairy cell leukemia

Published Date: 13 Mar 2023

Five out of six patients with relapsed or recurrent lymphoma responded to venetoclax alone or in combination with rituximab.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Accuracy of Skin Cancer Diagnosis Varies by Physician, Exam Method

2.

Investigating the Relationship Between GERD and Anxiety/Depression.

3.

Can patients receiving immunotherapy for cancer benefit from taking vitamin D supplements?

4.

Does pollution cause cancer?

5.

New BiTE Agent for Small Cell Lung Cancer Approved by the FDA.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot